← Back to headlines
MPM Bioventures Funds Divest $615,777 in Entrada Therapeutics Shares
Investment vehicles managed by MPM Bioventures have sold approximately $615,777 worth of shares in biotechnology firm Entrada Therapeutics. The transaction reflects routine portfolio adjustments by the venture capital group.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
